[1] TORRE-AMIONEG, ANKER SD, BOURGE RC, et al.Rwsults of a non-specific immunomodulation therapy in chronic heart failure(ACCLAIM trail):a placebo-controlled randomised trail[J].Lancet, 2016, 371(9608):228.
[2] PONIKOWSKI P, VOORS AA, ANKER SD, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC) Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J, 2016, 37(27):2129. doi: 10.1093/eurheartj/ehw128
[3] 殷伟贤.全球心力衰竭现状[J].中国心血管杂志, 2018, 23(1):11. doi: 10.3969/j.issn.1007-5410.2018.01.004
[4] 孟苗苗.心率变异性与心力衰竭病人房性心律失常的相关性研究[J].河南医学研究, 2017, 26(7):1251. doi: 10.3969/j.issn.1004-437X.2017.07.058
[5] MAESTRI R, PINNA GD, ALLEGRINI P, et al.Linear and non-linear indices of heart rate variability in chronic heart failure mutual interrelationships and prognostic value[J].Comput Cardiol, 2016, 32:981.
[6] YANG Z, YU X, YU ML.Effects of shensongyangxin capsule on heart rate turbulence and heart rate variablity in chronic heart failure[J].Chin Med J(Engl), 2013, 126(22):4389.
[7] RAMIRE J, LAGUNA P, BAYES DE LUNAA, et al.QT/RR and T-peak-to-end/RR curvatures and slopes in chronic heart failure:Relation to sudden cardiac death[J].J Electrocardiol, 2014, 47(6):842. doi: 10.1016/j.jelectrocard.2014.08.013
[8] TEIS MS, AREN R, ARCHIZA B, et al.Deep breathing heart rate variability is associated with Inspiratory muscle weakness in chronic heart failure[J].Physiother Res Int, 2013, 19(1):16.
[9] WU L, JIANG Z, LI C, et al.Prediction of heart rate variability on cardiac sudden death in heart failure patients:a systematic review[J].INT J CARDIOL, 2104, 174(3):875.
[10] 韩萍, 杨文静, 宋丽萍, 等.NT-proBNP对心力衰竭病人再入院率的预测价值[J].北京医学, 2018, 40(5):435.
[11] 郭晓琳.心率变异性分析临床应用研究近况[J].心血管病防治知识(学术版), 2017, 16(7):143.
[12] 王昌生, 黎雄, 岳晓荷.心力衰竭病人血清NT-proBNP、mAlb水平与肾功能的相关性[J].中西医结合心脑血管病杂志, 2018, 16(18):2664. doi: 10.12102/j.issn.1672-1349.2018.18.018
[13] FLATT A, ESCO MR.Heart rate variability stabilization in athletes:towards more convenient data acquisition[J].Clin Physiol Funct Imaging, 2016, 36(5):331. doi: 10.1111/cpf.2016.36.issue-5
[14] 李克强, 胡嘉涛, 邹海平, 等.心率变异时域对老年慢性心力衰竭预后危险分层的定量研究[J].中国现代医药杂志, 2014, 16(6):8.
[15] 杨新, 杨燕, 许国军.房性心律失常患者心率变异性研究[J].临床心电血杂志, 2014, 2(6):110.
[16] 张辉, 冯婧, 梁婷, 等.心率和心率变异性与心力衰竭及预后的相关性[J].中国动脉硬化杂志, 2014, 3(17):274.
[17] 杨美玲.心率变异性与心力衰竭患者房性心律失常发生的关系研究[J].现代诊断与治疗, 2014, 25(12):2818.
[18] 刘玉, 周利民, 张军.心率变异性对慢性心力衰竭病情评估及预后的应用价值[J].新疆医科大学学报, 2018, 3(41):291.
[19] 赵雪燕, 杨跃进, 倪新海, 等.左心衰竭患者B型利钠肽与心功能指标的相关性分析[J].中国循环杂志, 2006, 21(3):168. doi: 10.3321/j.issn:1000-3614.2006.03.004
[20] 周华三.检测NT-proBNP用于心力衰竭诊断的价值分析与评估[J].现代医学与健康研究, 2018, 2(3):89.
[21] 朱信坤.NT-proBNP在老年慢性心力衰竭诊断及预后判断的临床分析[J].中西医结合心血管病杂志, 2018, 6(17):59.
[22] 韩萍, 杨静文, 宋丽萍, 等.NT-proBNP对心力衰竭患者再入院率的预测价值[J].北京医学, 2018, 5(40):435.